[Prevention of primary hypoxic organ lesions in liver transplantation using appropiate perfusion technics with Hb-free perfusion solutions].
D000410:Alanine Transaminase / Q000378:metabolism; D000818:Animals; D001219:Aspartate Aminotransferases / Q000378:metabolism; D002208:Caproates / Q000494:pharmacology; D003065:Coenzyme A / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006454:Hemoglobins / Q000009:adverse effects*; D007035:Hypothermia; D007668:Kidney / Q000187:drug effects / Q000201:enzymology / Q000503:physiopathology; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D016031:Liver Transplantation; D009243:NAD / Q000494:pharmacology; D010101:Oxygen Consumption; D010313:Partial Pressure; D010477:Perfusion; D011773:Pyruvates / Q000494:pharmacology; D013552:Swine; D013997:Time Factors; D014021:Tissue Preservation; D014184:Transplantation, Homologous
D002208:Caproates; D006454:Hemoglobins; D011773:Pyruvates; D009243:NAD; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D005947:Glucose; D003065:Coenzyme A
Die Vermeidung primär hypoxischer Organschädigungen bei der Lebertransplantation durch entsprechende Perfusionsverfahren mit nicht Hb-haltigen Perfusionslösungen.